New piperidine derivative

A kind of piperidine compound, the technology of compound, is applied in the field of piperidine compound, can solve the problem such as undiscovered

Inactive Publication Date: 2008-11-05
MITSUBISHI TANABE PHARMA CORP
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, as a therapeutic agent for the above-mentioned various diseases (particularly for vomiting, depression, urinary disorders, etc.), no drug having an excellent tachykinin receptor antagonism (specifically, SP receptor antagonism) and at the same time has not been found. Compounds with sufficiently satisfactory safety profile, sustainability (metabolism, in vivo kinetics, and absorption), etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • New piperidine derivative
  • New piperidine derivative
  • New piperidine derivative

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0465](1) Dissolve 1.43g of 1-{N-(3,5-bistrifluoromethylbenzyl)-N-methyl}aminocarbonyl-2-(4-fluoro-2-methylphenyl) in 30ml of methanol )-4-oxopiperidine, to which 114 mg of sodium borohydride was added. The mixture was stirred at room temperature for 3 hours. Aqueous ammonium chloride solution and ethyl acetate were added to the reaction mixture, and after the mixture was stirred, the layers were separated. The organic layer was washed with water and brine, dried, and then the solvent was removed by distillation under reduced pressure. The residue was purified by silica gel column chromatography (chloroform:ethyl acetate=4:1) to give 0.99 g of 1-{N-(3,5-bistrifluoromethylbenzyl)-N-methyl}-aminocarbonyl -2-(4-fluoro-2-methylphenyl)-4-hydroxypiperidine, as shown in Table 1 below.

[0466] (2) 200 mg of the compound of (1) above was further purified by silica gel column chromatography (hexane:ethyl acetate=4:1) to provide 18 mg of (a) trans-1-{N-(3,5-bistris Fluoromethylbenzy...

Embodiment 2

[0468] Dissolve 200mg (2R)-1-[N-{1-(S)-(3,5-bistrifluoromethylphenyl)ethyl}-N-methyl]aminocarbonyl-2-( 4-Fluoro-2-methylphenyl)-4-oxopiperidine, 60 mg of sodium borohydride was added thereto, and the mixture was refluxed. While continuously refluxing the mixture, a mixed solvent of 1 ml of methanol and 5 ml of tetrahydrofuran was added dropwise thereto. After 5 hours, the reaction mixture was poured into water and the layers were separated. The aqueous layer was extracted with ethyl acetate, the combined organic layers were washed with water and saturated brine and dried, and then the solvent was removed by distillation under reduced pressure. The residue was purified by silica gel column chromatography (hexane:ethyl acetate=1:1-1:2) to provide 33 mg of (a)(2R,4R)-1-[N-{1-(S)-(3 , 5-bistrifluoromethylphenyl) ethyl}-N-methyl]aminocarbonyl-2-(4-fluoro-2-methylphenyl)-4-hydroxypiperidine and 160 mg (b) (2R , 4S)-1-[N-{1-(S)-(3,5-bistrifluoromethylphenyl)ethyl}-N-methyl]aminoca...

Embodiment 3

[0470] Using (2R)-1-[N-(3,5-bistrifluoromethylbenzyl)-N-methyl]aminocarbonyl-2-(4-fluoro-2-methylphenyl)-4-oxo Piperidine, treated in the same manner as in Example 2 to provide (a) (2R, 4R)-1-{N-(3,5-bistrifluoromethylbenzyl)-N-methyl}aminocarbonyl -2-(4-fluoro-2-methylphenyl)-4-hydroxypiperidine and (b)(2R,4S)-1-{N-(3,5-bistrifluoromethylbenzyl)- N-methyl}aminocarbonyl-2-(4-fluoro-2-methylphenyl)-4-hydroxypiperidine, as shown in Table 2 below.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
optical purityaaaaaaaaaa
optical purityaaaaaaaaaa
Login to view more

Abstract

The present invention provides a novel piperidine compound of the formula [I]: wherein Ring A represents an optionally substituted benzene ring, Ring B represents an optionally substituted benzene ring, R>1< represents an optionally substituted alkyl group, an optionally substituted hydroxyl group, etc., or a group of the formula: (a) wherein R>11< AND R>12< are the same or different, and each represents hydrogen atom, a substituted carbonyl group, a substituted sulfonyl group, an optionally substituted alkyl group, etc., R>2< represents hydrogen atom, etc., Z represents oxygen atom or a group represented by -N(R>3<)-, R>3< represents hydrogen atom or an alkyl group, etc., R>4< represents hydrogen atom or an alkyl group, etc.,or a pharmaceutically acceptable salt thereof.

Description

technical field [0001] The present invention relates to novel piperidine compounds having excellent tachykinin receptor antagonism. Background technique [0002] Tachykinin is a general name for a group of neuropeptides, and substance P (hereinafter referred to as SP), neurokinin-A, and neurokinin-B have been known in mammals. These peptides are known to exhibit various types of biological activities by binding to their corresponding receptors (neurokinin-1, neurokinin-2, neurokinin-3) present in vivo. Among them, SP is one of those with the longest history among neuropeptides and has been studied in detail. Its existence was confirmed in 1931 in extracts of horse intestinal tubes, and it is a peptide containing 11 amino acids, the structure of which was determined in 1971. [0003] SP widely exists in the peripheral nervous system, and it has physiological activities such as vasodilation, vascular permeability promotion, smooth muscle contraction, excessive nerve excitabi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07D211/46C07D211/58C07D211/62C07D211/54C07D211/74C07D401/04C07D401/12C07D401/14C07D405/12C07D409/12C07D417/04C07D417/12C07D473/34A61K31/451A61K31/454A61K31/4545A61K31/4709A61K31/497A61K31/513A61P29/00A61P25/04A61K31/445A61K38/00C07D409/04C07K5/02C07K5/06C07K5/083C07K5/087C07K5/097C07K5/103
CPCC07K5/0812C07D211/58C07D417/04C07K5/1008C07D405/12C07D409/12C07K5/0808C07D211/62C07D401/14C07D401/12C07K5/0202C07D409/04C07D211/74C07D417/12A61K38/00C07D473/34C07D211/54C07D211/46C07K5/06191C07D401/04C07K5/0821A61P1/00A61P11/14A61P13/00A61P25/00A61P25/06A61P29/00A61P37/00A61P37/02A61P37/08A61P9/00A61P9/12
Inventor 高桥政巳三宅努盛谷恭典浅井秀敏石井健敏河野理夏子
Owner MITSUBISHI TANABE PHARMA CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap